NRNextRounds

Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC

Claymont, De

SEC Form D ↗

Amount Raised

$455,025

Target Size

$455,025

Investors

11

Date Filed

2024-05-15

Dry powder breakdown

Est. Remaining

$218,033

Deployed

$236,992

52% deployed23 months remaining (4yr model)

Raised 100% of $455,025 target

Filing details

Fund vehicleAmytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC
IndustryVenture Capital Fund
Address2093 PHILADELPHIA PIKE, CLAYMONT, DE
Phone(360) 946-0604
Related personsView on SEC EDGAR ↗